 |
Facing Forward by Cutanea |
|---|
| この情報はストアのものより古い可能性がございます。 | ||||
|
価格 | 無料 | ダウンロード |
|
|---|---|---|---|---|
| ｼﾞｬﾝﾙ | メディカル | |||
サイズ | 61.2MB | |||
| 開発者 | Cutanea Life Sciences Inc. | |||
| 順位 |
| |||
| ﾘﾘｰｽ日 | 2017-08-14 04:20:11 | 評価 | 評価が取得できませんでした。 | |
| 互換性 | iOS 8.0以降が必要です。 iPhone、iPad および iPod touch 対応。 | |||
The Facing Forward app is a mobile application to help track your acne treatment. It offers features like: daily reminders, photo journal, dosing calendar, information for healthcare providers and pharmacy information.
INDICATIONS AND USAGE
AKTIPAK™ (erythromycin and benzoyl peroxide) Gel, 3%/5% is indicated for the topical treatment of acne vulgaris.
IMPORTANT SAFETY INFORMATION
Contraindications: AKTIPAK™ is contraindicated in those individuals who have shown hypersensitivity to any of its components.
Precautions: For topical use only; not for ophthalmic use. Concomitant topical acne therapy should be used with caution because a possible cumulative irritancy effect may occur, especially with the use of peeling, desquamating or abrasive agents. If severe irritation develops, discontinue use and institute appropriate therapy. The use of antibiotic agents may be associated with the overgrowth of nonsusceptible organisms. If this occurs, discontinue use and take appropriate measures. Avoid contact with eyes and all mucous membranes.
Pregnancy: It is not known whether AKTIPAK™ can cause fetal harm when administered to a pregnant woman. AKTIPAK™ should be given to a pregnant woman only if clearly needed. It is not known whether the ingredients of AKTIPAK™ are excreted in human milk. Therefore, caution should be exercised when erythromycin is administered to a nursing woman.
Pediatric Use: The safety and effectiveness of AKTIPAK™ in pediatric patients below 12 years of age have not been established.
Adverse Reactions: The most frequently reported adverse events reported in clinical trials include: dry skin, application site reaction, blepharitis, pruritus, and photosensitivity.
Please see accompanying full Prescribing Information and Important Safety Information. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/Safety/MedWatch/default.htm or call 1-800-FDA-1088.
For full Product Information, please visit http://www.aktipak.com/wp-content/themes/Aktipak/img/pdf/CUTA_11042_AKT-WEBSITE_DV1_021717_Desktop_FULL_PI.pdf
更新履歴
Fix for slideshow very first animation being a fade, but all others being normal
Phone numbers in Pharmacy section that are links and callable
Full screen video on rotation of the screen for How to Mix Fresh video
Fix for reminders only showing the same day after a load-up of the app
INDICATIONS AND USAGE
AKTIPAK™ (erythromycin and benzoyl peroxide) Gel, 3%/5% is indicated for the topical treatment of acne vulgaris.
IMPORTANT SAFETY INFORMATION
Contraindications: AKTIPAK™ is contraindicated in those individuals who have shown hypersensitivity to any of its components.
Precautions: For topical use only; not for ophthalmic use. Concomitant topical acne therapy should be used with caution because a possible cumulative irritancy effect may occur, especially with the use of peeling, desquamating or abrasive agents. If severe irritation develops, discontinue use and institute appropriate therapy. The use of antibiotic agents may be associated with the overgrowth of nonsusceptible organisms. If this occurs, discontinue use and take appropriate measures. Avoid contact with eyes and all mucous membranes.
Pregnancy: It is not known whether AKTIPAK™ can cause fetal harm when administered to a pregnant woman. AKTIPAK™ should be given to a pregnant woman only if clearly needed. It is not known whether the ingredients of AKTIPAK™ are excreted in human milk. Therefore, caution should be exercised when erythromycin is administered to a nursing woman.
Pediatric Use: The safety and effectiveness of AKTIPAK™ in pediatric patients below 12 years of age have not been established.
Adverse Reactions: The most frequently reported adverse events reported in clinical trials include: dry skin, application site reaction, blepharitis, pruritus, and photosensitivity.
Please see accompanying full Prescribing Information and Important Safety Information. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/Safety/MedWatch/default.htm or call 1-800-FDA-1088.
For full Product Information, please visit http://www.aktipak.com/wp-content/themes/Aktipak/img/pdf/CUTA_11042_AKT-WEBSITE_DV1_021717_Desktop_FULL_PI.pdf
更新履歴
Fix for slideshow very first animation being a fade, but all others being normal
Phone numbers in Pharmacy section that are links and callable
Full screen video on rotation of the screen for How to Mix Fresh video
Fix for reminders only showing the same day after a load-up of the app
ブログパーツ第二弾を公開しました！ホームページでアプリの順位・価格・周辺ランキングをご紹介頂けます。
ブログパーツ第2弾！
アプリの周辺ランキングを表示するブログパーツです。価格・順位共に自動で最新情報に更新されるのでアプリの状態チェックにも最適です。
ランキング圏外の場合でも周辺ランキングの代わりに説明文を表示にするので安心です。
サンプルが気に入りましたら、下に表示されたHTMLタグをそのままページに貼り付けることでご利用頂けます。ただし、一般公開されているページでご使用頂かないと表示されませんのでご注意ください。
幅200px版
幅320px版
お気に入りのアプリをご紹介頂くためのブログパーツです。アプリの価格や順位表示は毎日自動更新♪
サンプルが気に入りましたら、下に表示されたHTMLタグをそのままページに貼り付けることでご利用頂けます。
※配信を停止させていただく可能性もございますので、タグの改変はご遠慮ください。
Now Loading...
「iPhone & iPad アプリランキング」は、最新かつ詳細なアプリ情報をご紹介しているサイトです。
お探しのアプリに出会えるように様々な切り口でページをご用意しております。
「メニュー」よりぜひアプリ探しにお役立て下さい。
Presents by $$308413110 スマホからのアクセスにはQRコードをご活用ください。 →
Now loading...